PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.
|ClinicalTrials.gov Identifier: NCT01664221|
Recruitment Status : Unknown
Verified August 2012 by Azidus Brasil.
Recruitment status was: Not yet recruiting
First Posted : August 14, 2012
Last Update Posted : August 14, 2012
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||October 2013|
|Estimated Study Completion Date :||October 2013|